Improving Compounding Safety: New Regulations and Options for Institutional Insourcing
With increasing regulatory oversight for sterile compounding and a limited ability to assure the quality of compounded sterile products obtained from external sources, many hospital pharmacies are moving to insource these products.
Second Look at Utilization of a Closed-System Transfer Device (PhaSeal)
The Phaseal closed-system transfer device can extend the beyond-use date of pharmaceuticals, thereby reducing waste.
Utility of the PhaSeal Closed System Drug Transfer Device
The Phaseal closed system drug transfer device provides a mechanical barrier to the entry of contaminants into sterile solutions for up to 168 hours.
Specialty Pharmacy: Status and Future Direction
Over the last 20 years, specialty pharmacy has grown and changed significantly to better manage high-cost drugs with challenging reimbursement issues.
2 Clarke Drive Cranbury, NJ 08512